ArticleOncotarget2019

Risk of venous and arterial thromboembolic events associated with tyrosine kinase inhibitors in advanced thyroid cancer: a meta-analysis and systematic review.

Yang Bai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.